Abstract
Objectives
Alterations in the prostaglandin-D–system have been found in animal sleep experiments and disorders that present with hypersomnia or sleep disturbances. The recently demonstrated involvement of the leptomeningeal lipocalin–type prostaglandin–Dsynthase (L–PGDS) (β–trace) in human physiological sleep encouraged us to investigate its role in the pathophysiology of narcolepsy.
Methods
In a pilot study, serum LPGDS and melatonin concentrations were assessed in 14 narcoleptic patients during undisturbed sleep and total sleep deprivation, compared with those from 14 healthy controls during undisturbed sleep. Excessive daytime sleepiness was measured by a standardized questionnaire (Epworth sleepiness scale, ESS).
Results
In narcoleptic patients, markedly increased baseline L–PGDS levels were significantly correlated with the ESS score, but not with the degree of cataplexy. Serum L–PGDS concentrations in patients as well as in controls followed a time–dependent fluctuation with evening increases, highest values during the night and in the morning. Compared with controls, patients exhibited significant/increased amplitude of circulating L–PGDS without any suppression by total sleep deprivation.
Conclusion
These findings indicate that the prostaglandin–D–system contributes to the pathophysiology of narcolepsy, e. g. the regulation of excessive daytime sleepiness. Since it has been suggested that L–PGDS is also involved in neurodegenerative disorders, there may be a more specific role of the prostaglandin– D–system in narcoleptic aetiogenesis. Moreover, its linkage with the immune system as well as with human sleep regulation offers a direct access for investigating both systems.
Similar content being viewed by others
References
American Thoracic Society (1989) Indications and standards for cardiopulmonary sleep studies.Am Rev Respir Dis 139:559–567
Beuckmann CT, Yanagisawa M (2002) Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation. J Mol Med 80:329–342
Cross EM, Chaffin WW (1982) Use of the binomial theorem in interpreting results of multiple tests of significance. Educational and Psychological Management 42:25–34
Dauvilliers Y, Baumann CR, Carlander B, Bischof M, Blatter T, Lecendreux M, Maly F, Besset A, Touchon J, Billiard M, Tafti M, Bassetti CL (2003) CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry 74(12):1667–1673
Eguchi Y, Eguchi N,Oda H, Seiki K, Kijima Y,Matsu-Ura Y,Urade Y, Hayaishi O (1997) Expression of lipocalin-type prostaglandin D synthase (β-trace) in human heart and its accumulation in the coronary circulation of angina patients. Proc Natl Acad Sci USA 94:14689–14694
Hayaishi O (1996) Tryptophan, oxygenase, and sleep. Adv Exp Med Biol 398:3–11
Hirawa N, Uehara Y,Yamakado M, Toya Y, Gomi T, Ikeda T, Eguchi Y, Takagi M, Oda H, Seiki K, Urade Y, Umemura S (2002) Lipocalin-type prostaglandin D synthase in essential hypertension. Hypertension 39(2Pt2):449–454
Johns MW (2000) Sensitivity and specificity of the multiple sleep latency test (MSLT), maintenance of wakefulness test and the Epworth sleepiness scale: failure of the MSLT as a gold standard. J Sleep Res 9:5–11
Jordan W, Tumani H, Cohrs S, Eggert S, Rodenbeck A, Brunner E, Rüther E, Hajak G (2004) Prostaglandin-D-synthase (β-trace) and melatonin in human healthy sleep. Sleep 27(5):867–874
Krahn LE, Pankratz VS, Oliver L, Boeve BF, Silber MH (2002) Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status. Sleep 25(7):733–736
Melegos DN, Freedman MS, Diamandis EP (1997) Prostaglandin D synthase concentration in cerebrospinal fluid and serum of patients with neurological disorders. Prostaglandins 54:463–474
Melegos DN, Grass L, Pierratos A, Diamandis EP (1999) Highly elevated levels of prostaglandin D synthase in the serum of patients with renal failure. Urology 53:32–37
Nishino S, Mignot E, Kilduff TS, Sakai T, Hayaishi O, Dement WC (1990) Prostaglandin E2 levels in cerebrospinal fluid of normal and narcoleptic dogs. Biol Psychiatry 28:904–910
Onoe H, Ueno R, Fujita I, Nishino H, Oomura Y, Hayaishi O (1988) Prostaglandin D2, a cerebral sleepinducing substance in monkeys. Proc Natl Acad Sci USA 85:4082–4086
Pinzar E, Kanaoka Y, Inui T, Eguchi N, Urade Y, Hayaishi O (2000) Prostaglandin D synthase gene is involved in the regulation of non-rapid eye movement sleep. Proc Natl Acad Sci USA 97(9):4903–4907
Ragolia L, Palaia T, Frese L, Fishbane S, Maesaka JK (2001) Prostaglandin D2 synthase induces apoptosis in PC12 neuronal cells. Neuroreport 12(12):2623–2628
Rechtschaffen A,Kales A (1968) A manual for standardized terminology, techniques and scoring system for sleep stages of human subjects. Washington, DC: Public Health Service, US Government Printing Office:1–12
Reiber H (2003) Proteins in cerebrospinal fluid and blood: Barriers, CSF flow rate and source-related dynamics. Restor Neurol Neurosci 21:79–96
Rodenbeck A, Huether G, Rüther E, Hajak G (1998) Altered circadian melatonin secretion patterns in relation to sleep in patients with chronic sleepwake rhythm disorders. J Pineal Res 25:201–210
Scammell TE (2003) The neurobiology, diagnosis, and treatment of narcolepsy. Ann Neurol 53:154–166
Tumani H, Nau R, Felgenhauer K (1998) β-trace protein in cerebrospinal fluid: a blood-CSF barrier-related evaluation in neurological diseases. Ann Neurol 44:882–889
Urade Y, Hayaishi O (1999) Prostaglandin D2 and sleep regulation. Biochem Biophys Acta 1436:606–615
Watanabe K, Urade Y, Mäder M, Murphy C, Hayaishi O (1994) Identification of β-trace as prostaglandin D synthase. Biochem Biophys Res Commun 203(2):1110–1116
Wu MF, John J, Maidment N, Lam HA, Siegel JM (2002) Hypocretin release in normal and narcoleptic dogs after food and sleep deprivation, eating, and movement. Am J Physiol Regul Integr Comp Physiol 283(5):R1079–R1086
Zeitzer JM, Buckmaster CL, Parker KJ, Hauck CM, Lyons DM, Mignot E (2003) Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness. J Neurosci 23(8):3555–3560
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jordan, W., Tumani, H., Cohrs, S. et al. Narcolepsy. J Neurol 252, 1372–1378 (2005). https://doi.org/10.1007/s00415-005-0870-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-005-0870-4